Background : The aberrant STAT3 signaling promotes initiation and progression of human cancers by either inhibiting apoptosis or inducing cell proliferation, angiogenesis, invasion, and metastasis. This study aims to investigate the role of STAT3 and its phosphorylation status in resveratrol-mediated suppression of cervical cancer. Methods : The effects of resveratrol on cervical tumor growth were also determined by examining the tumor tissues and their histological changes and the volume and weight of tumor tissues grown from Hela cells injected in female athymic BALB/C nude mice following the pretreatment regimen and the treatment regimen. Resveratrol structure and targets interaction virtual screening was performed using molecular docking program Autodock Vina. The phosphorylated STAT3, EMT molecular markers and ECM degradation enzymes protein levels were determined using Western blotting. Results : Proliferation and the colony formation of Hela cells were inhibited after resveratrol treatment in both dose- and time- dependent manner. Resveratrol inhibited migration and invasion of Hela cells. Molecular docking analysis showed that resveratrol interacted with STAT3 at a pocket composed of 11 amino acidic residues. Treatment with resveratrol resulted in decreases in the level of phosphorylation of STAT3 at Tyr705 but not Ser727, and no obvious changes in the protein level of STAT3 in Hela cells and SiHa cells. Pretreatment or treatment with resveratrol resulted in decreases in the IL-6-induced phosphorylation level of STAT3Tyr705 in Hela cells and SiHa cells, compared with those of treatment with IL-6. Reduced STAT3Tyr705 phosphorylation after STAT3 inhibitors S3I201 enhanced inhibition of invasion potential of Hela cells and SiHa cells treated with Resveratrol. Resveratrol decreases the N-Cadherin, Vimentin, MMP-3, MMP-13 protein level and increases the E-Cadherin protein level in a dose-dependent manner. The tumor size, volume, and weight, and the N-Cadherin, Vimentin, MMP-3, and MMP-13 protein level were significantly decreased, and the E-Cadherin protein level was increased, and the tumors were histologically damaged as revealed by H&E staining in both the resveratrol pretreatment group and the resveratrol treatment group and the magnitude of changes was higher in the former than that of the latter. Conclusion : Resveratrol inhibits growth and metastatic potential of cervical cancer through blocking STAT3Tyr705 phosphorylation.